Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Kazanorgsintez recommended that dividends be paid for 2023

16:31 KZOS

En+ Group to double its network of charging stations for electric vehicles by the end of 2024

12:48 ENPG

Europlan reports for the first quarter of 2024

12:37 LEAS

Sovcomflot reports for the first quarter of 2024

12:21 FLOT

Norilsk Nickel may start producing metal in Bahrain

09:51 GMKN

Moscow Exchange plans to conduct ten pre-IPO transactions before the end of the year

09:43 MOEX

Positive Technologie plans to gain a foothold in the cyber resilience market

09:37 POSI

TCS Holding is preparing a new dividend policy

09:23 TCSG

Moscow Exchange looks closely at Asian markets

09:17 MOEX

Moscow Exchange will develop grain trading

Yesterday at 15:25 MOEX